|
⚲
|
| Keyboard |
| Fhmls IX LP | |
|---|---|
| Firm | Frazier Life Sciences Management LP |
| Address | 601 Union Street Suite 3200 Seattle, WA 98101 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Frazier Life Sciences Management LP | |||||
| Frazier Life Sciences IX LP | 021-297918 | Executive Officer | 418.9 M of 418.9 M |
596.5 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tarsus Pharmaceuticals Inc TARS
Series B Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,390,376 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Buy | 312,500 | $16.00 | 5,000,000 |
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 214,281 | ||
|
Tarsus Pharmaceuticals Inc TARS
Common Stock
|
2020-10-20 | Conversion | 1,390,376 | ||
|
Tarsus Pharmaceuticals Inc TARS
Series C Preferred Stock · derivative
|
2020-10-20 | Conversion | 214,281 | ||
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2020-06-12 | Other | 1,456,854 | $0.00 | |
|
Passage Bio Inc PASG
Series A-1 Preferred Stock · derivative
|
2020-03-03 | Conversion | 2,977,242 | $0.00 | |
|
Passage Bio Inc PASG
Common Stock
|
2020-03-03 | Conversion | 432,802 | ||
|
Passage Bio Inc PASG
Common Stock
|
2020-03-03 | Buy | 550,000 | $18.00 | 9,900,000 |
|
Passage Bio Inc PASG
Common Stock
|
2020-03-03 | Conversion | 1,049,175 | ||
|
Passage Bio Inc PASG
Common Stock
|
2020-03-03 | Conversion | 2,977,242 | ||
|
Passage Bio Inc PASG
Series B Preferred Stock · derivative
|
2020-03-03 | Conversion | 432,802 | $0.00 | |
|
Passage Bio Inc PASG
Series A-2 Preferred Stock · derivative
|
2020-03-03 | Conversion | 1,049,175 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Convertible Promissory Notes · derivative
|
2019-10-29 | Conversion | |||
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2019-10-29 | Conversion | 1,353,640 | $15.20 | 20,575,328 |
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2019-10-29 | Buy | 1,052,631 | $19.00 | 19,999,989 |
|
Mirum Pharmaceuticals Inc MIRM
Common Stock
|
2019-07-22 | Conversion | 3,116,912 | ||
|
Mirum Pharmaceuticals Inc MIRM
Series A Preferred Stock · derivative
|
2019-07-22 | Conversion | 24,935,300 | $0.00 | |
|
Mirum Pharmaceuticals Inc MIRM
Common Stock
|
2019-07-22 | Buy | 450,000 | $15.00 | 6,750,000 |